18 Jun 2026

Reference: CIR-2026-00000093

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the Emirates Drug Establishment for perusal and adherence to what is stated.

Circular No. (25/2026)– Voluntary recall one lot of IMULDOSA (Ustekinumab) 130 mg product

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Voluntary recall one lot of IMULDOSA (Ustekinumab) 130 mg product.pdf

download